Clinical Trial Update: Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating acetazolamide to prevent remifentanil-induced hyperalgesia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperalgesia
• Opioid-related Disorders

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• Remifentanil (remifentanil)

Snippet

Sponsor: University of Chile | Conditions: Hyperalgesia, Opioid-Related Disorders | Phase 4 | Status: COMPLETED